CDKN2B rs1333040: Understanding Cardiovascular Risk Associations
The genetic variant rs1333040 is a well-studied marker located on chromosome 9p21. It is frequently associated in scientific literature with an increased susceptibility to myocardial infarction and intracranial aneurysm.
What each genotype means
Baseline cardiovascular risk profile
Research suggests that individuals with this genotype do not carry the specific risk-associated T allele at this position. Large-scale studies indicate that this genotype is associated with a lower relative risk of coronary artery disease compared to carriers of the T allele.
The frequency of this genotype varies significantly by ancestry, being less common than the T-allele-containing genotypes in many populations.
Increased cardiovascular risk marker
This genotype includes one copy of the T allele, which has been consistently associated in genome-wide association studies with an increased susceptibility to coronary artery disease and myocardial infarction. Statistical models suggest this risk may be additive, meaning carrying one copy confers a moderate increase in risk compared to the CC genotype.
This is a common genotype observed across many global populations.
Elevated cardiovascular risk marker
This genotype includes two copies of the T allele, which are robustly associated with a higher statistical risk for cardiovascular conditions, including coronary artery disease and myocardial infarction, compared to those with one or no copies of the allele. Research indicates that the T allele at this locus may influence vascular smooth muscle cell function and inflammatory responses, though individual risk remains influenced by a wide range of lifestyle and environmental factors.
This genotype is common and represents a significant portion of the population in many ancestral groups, often being the predominant genotype in some studies.
What is rs1333040 and Where is it Located?
The variant rs1333040 is a single nucleotide polymorphism (SNP) situated on chromosome 9 at position 22,083,405 (GRCh38). This specific region of the genome is highly significant in cardiovascular research. While often discussed in the context of the CDKN2B gene, the SNP is physically located within the CDKN2B-AS1 region, which encodes a long non-coding antisense RNA molecule. This molecule is thought to play a role in the long-range transcriptional regulation of nearby genes, including CDKN2A and CDKN2B. Because this region does not code for a protein directly, researchers focus on how these genetic variations might influence the expression of neighboring genes that are critical for vascular health and smooth muscle cell regulation.
The Role of the CDKN2B Region
The CDKN2B gene and its surrounding genomic neighborhood are essential for regulating the cell cycle. Research using murine models has suggested that mechanisms involving CDKN2A and CDKN2B are linked to the proliferation of vascular smooth muscle cells. In the context of cardiovascular health, the stability of coronary plaques is a major area of study. The regulation of these cells is vital, as abnormal proliferation or dysfunction can contribute to the development of atherosclerosis and the subsequent risk of acute coronary syndromes. By influencing the expression of these genes, variants in this region may alter the biological environment of the arterial wall, potentially impacting how the body responds to vascular stress over a lifetime.
Research Associations and Evidence Strength
The association between rs1333040 and cardiovascular disease is considered well-replicated across numerous genome-wide association studies (GWAS). Large-scale meta-analyses have consistently identified this SNP as a marker for increased risk of myocardial infarction. Additionally, research has linked this variant to an increased risk of intracranial aneurysm. While the statistical evidence for these associations is robust, it is important to note that these findings represent population-level correlations rather than individual predictions. Genetic risk is only one component of cardiovascular health, which is also heavily influenced by environmental factors, lifestyle choices, and other genetic markers. The evidence strength is generally categorized as moderate to strong in the context of identifying susceptibility, but it does not function as a diagnostic tool for any specific individual.
Population Frequency and Distribution
The rs1333040 variant is considered a common SNP in human populations. Because it is common, many individuals carry at least one copy of the risk-associated allele. The distribution of the C and T alleles varies across different ancestral groups, but the variant is widely present globally. In genetic studies, researchers often compare the frequency of these alleles between case groups (individuals with a history of myocardial infarction) and control groups to determine the odds ratio of the association. Because the variant is common, it is a frequent subject in large-scale genetic databases like gnomAD, which help scientists understand how allele frequencies differ across diverse populations. This widespread presence underscores the importance of studying the variant to better understand the polygenic nature of cardiovascular disease risk.
What You Can and Cannot Do With This Information
Understanding your genotype for rs1333040 provides insight into your genetic predisposition as identified by scientific research, but it is not a medical diagnosis. You cannot use this information to predict with certainty whether you will experience a cardiovascular event. Genetic markers are just one piece of a much larger puzzle that includes blood pressure, cholesterol levels, diet, exercise, and smoking status. If you have concerns about your cardiovascular health or your family history, the most effective step is to consult with a healthcare professional. They can evaluate your overall risk profile using established clinical tools. Never use genetic information to make changes to prescribed medications or health regimens without first discussing these decisions with your doctor or a qualified pharmacist.
How common is this variant?
The rs1333040 variant is a common SNP found across diverse human populations, with both the C and T alleles appearing at significant frequencies globally.
Frequently asked questions
Does having the T allele mean I will have a heart attack?
No. Having the T allele is associated with a statistically higher risk of myocardial infarction at a population level, but it does not guarantee that an individual will experience a heart attack. Cardiovascular health is influenced by many factors, including lifestyle and other genetic markers.
Is rs1333040 the only gene involved in heart disease?
No. Cardiovascular disease is a complex, polygenic condition, meaning it is influenced by many different genes and environmental factors. rs1333040 is just one of many variants that have been identified by researchers as contributing to overall risk.
Should I get tested for this SNP?
Genetic testing for common variants like rs1333040 is generally not used in routine clinical practice to predict individual heart disease risk. If you are concerned about your heart health, you should speak with a doctor about standard clinical screenings like blood pressure and cholesterol tests.
Can I change my risk if I have the T/T genotype?
While you cannot change your genetics, you can manage your cardiovascular risk through lifestyle choices. Maintaining a healthy diet, regular exercise, and avoiding smoking are standard recommendations for heart health regardless of your genetic profile.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1333040?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B
This variant is located in the CDKN2B-AS1 region and is a well-established risk factor for primary open-angle glaucoma and associated optic disc traits.
This variant is a well-established risk factor for coronary artery disease and related cardiovascular conditions.
This variant is associated with increased risk for coronary artery disease and related cardiovascular conditions.
This SNP has been identified as a susceptibility marker for meningioma risk in genome-wide association studies.
A noncoding variant modulating the senescence pathway at chromosome 9p21 linked to differential survival rates into extreme age (>90 years).